世界の体外毒性検査市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV12327)
◆英語タイトル:Global In Vitro Toxicology Testing Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12327
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:127
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは体外毒性検査の世界市場について調査・分析した資料です。種類別(細胞培養技術、ハイスループット技術、細胞イメージング技術、トキシコゲノミクス)の市場規模、用途別(製薬・バイオ医薬品産業、化粧品・家庭用品産業、食品産業、化学産業)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別体外毒性検査の競争状況、市場シェア
・世界の体外毒性検査市場:種類別市場規模 2015年-2020年(細胞培養技術、ハイスループット技術、細胞イメージング技術、トキシコゲノミクス)
・世界の体外毒性検査市場:種類別市場規模予測 2021年-2026年(細胞培養技術、ハイスループット技術、細胞イメージング技術、トキシコゲノミクス)
・世界の体外毒性検査市場:用途別市場規模 2015年-2020年(製薬・バイオ医薬品産業、化粧品・家庭用品産業、食品産業、化学産業)
・世界の体外毒性検査市場:用途別市場規模予測 2021年-2026年(製薬・バイオ医薬品産業、化粧品・家庭用品産業、食品産業、化学産業)
・北米の体外毒性検査市場分析:米国、カナダ
・ヨーロッパの体外毒性検査市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの体外毒性検査市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の体外毒性検査市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの体外毒性検査市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):SGS、Covance、Bio-Rad Laboratories、Qiagen、GE Healthcare、Eurofins Scientific、Merck、Thermo Fisher、Charles River Laboratories International、Catalent、Cyprotex、Promega、Gentronix Limited、Ascendance Biotechnology、MB Research Laboratories
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
Europe is projected to account for the largest share of the global market. The demand for in vitro toxicology testing in Europe is driven by the increasing number of investments in research and innovation by the European Commission to develop alternative methods to animal testing. The European Union has been a leader in supporting research to advance the development and validation of in vitro toxicology testing protocols for regulatory purposes.

Market Analysis and Insights: Global In Vitro Toxicology Testing Market
The global In Vitro Toxicology Testing market size is projected to reach US$ 7144.7 million by 2026, from US$ 6759.3 million in 2020, at a CAGR of 5.3%% during 2021-2026.

Global In Vitro Toxicology Testing Scope and Market Size
In Vitro Toxicology Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In Vitro Toxicology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
SGS
Covance
Bio-Rad Laboratories
Qiagen
GE Healthcare
Eurofins Scientific
Merck
Thermo Fisher
Charles River Laboratories International
Catalent
Cyprotex
Promega
Gentronix Limited
Ascendance Biotechnology
MB Research Laboratories

Market segment by Type, the product can be split into
Cell culture technology
High-throughput technology
Cellular imaging technology
Toxicogenomics
Market segment by Application, split into
Pharmaceuticals & biopharmaceuticals industry
Cosmetics and household products industry
Food industry
Chemicals industry

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In Vitro Toxicology Testing Revenue
1.4 Market by Type
1.4.1 Global In Vitro Toxicology Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell culture technology
1.4.3 High-throughput technology
1.4.4 Cellular imaging technology
1.4.5 Toxicogenomics
1.5 Market by Application
1.5.1 Global In Vitro Toxicology Testing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceuticals & biopharmaceuticals industry
1.5.3 Cosmetics and household products industry
1.5.4 Food industry
1.5.5 Chemicals industry
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global In Vitro Toxicology Testing Market Perspective (2015-2026)
2.2 Global In Vitro Toxicology Testing Growth Trends by Regions
2.2.1 In Vitro Toxicology Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In Vitro Toxicology Testing Historic Market Share by Regions (2015-2020)
2.2.3 In Vitro Toxicology Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In Vitro Toxicology Testing Market Growth Strategy
2.3.6 Primary Interviews with Key In Vitro Toxicology Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top In Vitro Toxicology Testing Players by Market Size
3.1.1 Global Top In Vitro Toxicology Testing Players by Revenue (2015-2020)
3.1.2 Global In Vitro Toxicology Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global In Vitro Toxicology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In Vitro Toxicology Testing Market Concentration Ratio
3.2.1 Global In Vitro Toxicology Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In Vitro Toxicology Testing Revenue in 2019
3.3 In Vitro Toxicology Testing Key Players Head office and Area Served
3.4 Key Players In Vitro Toxicology Testing Product Solution and Service
3.5 Date of Enter into In Vitro Toxicology Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global In Vitro Toxicology Testing Historic Market Size by Type (2015-2020)
4.2 Global In Vitro Toxicology Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global In Vitro Toxicology Testing Market Size by Application (2015-2020)
5.2 Global In Vitro Toxicology Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America In Vitro Toxicology Testing Market Size (2015-2020)
6.2 In Vitro Toxicology Testing Key Players in North America (2019-2020)
6.3 North America In Vitro Toxicology Testing Market Size by Type (2015-2020)
6.4 North America In Vitro Toxicology Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe In Vitro Toxicology Testing Market Size (2015-2020)
7.2 In Vitro Toxicology Testing Key Players in Europe (2019-2020)
7.3 Europe In Vitro Toxicology Testing Market Size by Type (2015-2020)
7.4 Europe In Vitro Toxicology Testing Market Size by Application (2015-2020)

8 China
8.1 China In Vitro Toxicology Testing Market Size (2015-2020)
8.2 In Vitro Toxicology Testing Key Players in China (2019-2020)
8.3 China In Vitro Toxicology Testing Market Size by Type (2015-2020)
8.4 China In Vitro Toxicology Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan In Vitro Toxicology Testing Market Size (2015-2020)
9.2 In Vitro Toxicology Testing Key Players in Japan (2019-2020)
9.3 Japan In Vitro Toxicology Testing Market Size by Type (2015-2020)
9.4 Japan In Vitro Toxicology Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia In Vitro Toxicology Testing Market Size (2015-2020)
10.2 In Vitro Toxicology Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In Vitro Toxicology Testing Market Size by Type (2015-2020)
10.4 Southeast Asia In Vitro Toxicology Testing Market Size by Application (2015-2020)

11 India
11.1 India In Vitro Toxicology Testing Market Size (2015-2020)
11.2 In Vitro Toxicology Testing Key Players in India (2019-2020)
11.3 India In Vitro Toxicology Testing Market Size by Type (2015-2020)
11.4 India In Vitro Toxicology Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America In Vitro Toxicology Testing Market Size (2015-2020)
12.2 In Vitro Toxicology Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America In Vitro Toxicology Testing Market Size by Type (2015-2020)
12.4 Central & South America In Vitro Toxicology Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 SGS
13.1.1 SGS Company Details
13.1.2 SGS Business Overview
13.1.3 SGS In Vitro Toxicology Testing Introduction
13.1.4 SGS Revenue in In Vitro Toxicology Testing Business (2015-2020))
13.1.5 SGS Recent Development
13.2 Covance
13.2.1 Covance Company Details
13.2.2 Covance Business Overview
13.2.3 Covance In Vitro Toxicology Testing Introduction
13.2.4 Covance Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.2.5 Covance Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview
13.3.3 Bio-Rad Laboratories In Vitro Toxicology Testing Introduction
13.3.4 Bio-Rad Laboratories Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 Qiagen
13.4.1 Qiagen Company Details
13.4.2 Qiagen Business Overview
13.4.3 Qiagen In Vitro Toxicology Testing Introduction
13.4.4 Qiagen Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.4.5 Qiagen Recent Development
13.5 GE Healthcare
13.5.1 GE Healthcare Company Details
13.5.2 GE Healthcare Business Overview
13.5.3 GE Healthcare In Vitro Toxicology Testing Introduction
13.5.4 GE Healthcare Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.5.5 GE Healthcare Recent Development
13.6 Eurofins Scientific
13.6.1 Eurofins Scientific Company Details
13.6.2 Eurofins Scientific Business Overview
13.6.3 Eurofins Scientific In Vitro Toxicology Testing Introduction
13.6.4 Eurofins Scientific Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.6.5 Eurofins Scientific Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck In Vitro Toxicology Testing Introduction
13.7.4 Merck Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Thermo Fisher
13.8.1 Thermo Fisher Company Details
13.8.2 Thermo Fisher Business Overview
13.8.3 Thermo Fisher In Vitro Toxicology Testing Introduction
13.8.4 Thermo Fisher Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.8.5 Thermo Fisher Recent Development
13.9 Charles River Laboratories International
13.9.1 Charles River Laboratories International Company Details
13.9.2 Charles River Laboratories International Business Overview
13.9.3 Charles River Laboratories International In Vitro Toxicology Testing Introduction
13.9.4 Charles River Laboratories International Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.9.5 Charles River Laboratories International Recent Development
13.10 Catalent
13.10.1 Catalent Company Details
13.10.2 Catalent Business Overview
13.10.3 Catalent In Vitro Toxicology Testing Introduction
13.10.4 Catalent Revenue in In Vitro Toxicology Testing Business (2015-2020)
13.10.5 Catalent Recent Development
13.11 Cyprotex
10.11.1 Cyprotex Company Details
10.11.2 Cyprotex Business Overview
10.11.3 Cyprotex In Vitro Toxicology Testing Introduction
10.11.4 Cyprotex Revenue in In Vitro Toxicology Testing Business (2015-2020)
10.11.5 Cyprotex Recent Development
13.12 Promega
10.12.1 Promega Company Details
10.12.2 Promega Business Overview
10.12.3 Promega In Vitro Toxicology Testing Introduction
10.12.4 Promega Revenue in In Vitro Toxicology Testing Business (2015-2020)
10.12.5 Promega Recent Development
13.13 Gentronix Limited
10.13.1 Gentronix Limited Company Details
10.13.2 Gentronix Limited Business Overview
10.13.3 Gentronix Limited In Vitro Toxicology Testing Introduction
10.13.4 Gentronix Limited Revenue in In Vitro Toxicology Testing Business (2015-2020)
10.13.5 Gentronix Limited Recent Development
13.14 Ascendance Biotechnology
10.14.1 Ascendance Biotechnology Company Details
10.14.2 Ascendance Biotechnology Business Overview
10.14.3 Ascendance Biotechnology In Vitro Toxicology Testing Introduction
10.14.4 Ascendance Biotechnology Revenue in In Vitro Toxicology Testing Business (2015-2020)
10.14.5 Ascendance Biotechnology Recent Development
13.15 MB Research Laboratories
10.15.1 MB Research Laboratories Company Details
10.15.2 MB Research Laboratories Business Overview
10.15.3 MB Research Laboratories In Vitro Toxicology Testing Introduction
10.15.4 MB Research Laboratories Revenue in In Vitro Toxicology Testing Business (2015-2020)
10.15.5 MB Research Laboratories Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

SGS、Covance、Bio-Rad Laboratories、Qiagen、GE Healthcare、Eurofins Scientific、Merck、Thermo Fisher、Charles River Laboratories International、Catalent、Cyprotex、Promega、Gentronix Limited、Ascendance Biotechnology、MB Research Laboratories

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の体外毒性検査市場2026:インサイト・予測(Global In Vitro Toxicology Testing Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。